Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial

Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added site revision v3.4.2 to the history and removed an older funding notice and revision (v3.4.1). These edits affect display metadata rather than the trial record data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T12:43:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide funding notice and updated the page version to v3.4.1. The previous version v3.4.0 was removed.
    Difference
    0.9%
    Check dated 2026-02-04T10:13:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI changes add a Show glossary option, color-coded highlights for record changes, and a revision tag showing v3.4.0 (with No FEAR Act Data labeling updates). No substantive study content or functionality was altered.
    Difference
    1%
    Check dated 2026-01-28T05:09:14.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision history shows a new entry for version v3.3.4 and removal of v3.3.3, indicating an administrative update to the page's history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:15.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Revision: v3.3.3 notice and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 notes from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T10:21:46.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new revision (v3.3.2) was added to the history. It includes the last known status (Verified, Unknown status) and sponsor location Tianjin Medical University Cancer Institute and Hospital as of 2022-11.
    Difference
    1%
    Check dated 2025-12-01T17:38:54.000Z thumbnail image

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.